In vitro and in animal models, GHK-Cu has been studied in research into
Phase 2 dose-finding trial (Lancet 2021) showed clear dose-response from 0.3 mg up to 4.5 mg/week, but 2.4 mg is the dose Novo Nordisk advanced into Phase 3 and is the most commonly self-reported community ceiling
What I would say is that 190 food histories converging on one ingredient, and traceback converging on one supplier, are most consistent with a single contaminated product rather than something broader
For any combination, verify with the Peptide Unit Converter
Often referred to as a Structural Architect, this 5mg format allows researchers to map out the precise pathways involved in cellular migration and extracellular-matrix organization
This page is an educational research reference, not medical advice